Aug 13 (Reuters) - Baxter International Inc ( BAX ):
* BAXTER ANNOUNCES DEFINITIVE AGREEMENT TO DIVEST ITS
VANTIVE
KIDNEY CARE SEGMENT TO CARLYLE FOR $3.8 BILLION
* BAXTER INTERNATIONAL INC ( BAX ) - FOLLOWING COMPLETION OF PENDING
SALE
OF KIDNEY CARE, TARGETING OPERATIONAL SALES GROWTH OF 4% TO 5%
ANNUALLY
* BAXTER: EXPECTS TO FULLY OFFSET STRANDED COSTS AND LOSS OF
TSA
INCOME IN 2027 THROUGH COST CONTAINMENT INITIATIVES
* BAXTER INTERNATIONAL ( BAX ) - FOR 2025, SEES ADJUSTED OPERATING
MARGIN
OF ABOUT 16.5% ON A CONTINUING OPERATIONS BASIS
Source text for Eikon:
Further company coverage:
(Reuters.Briefs@thomsonreuters.com)